Interregulation between fragile X mental retardation protein and methyl CpG binding protein 2 in the mouse posterior cerebral cortexHUMAN MOLECULAR GENETICSIF3.22020-10-218OAAI
Identification of a molecular locus for normalizing dysregulated GABA release from interneurons in the Fragile X brainMOLECULAR PSYCHIATRYIF10.12018-09-1751OAAI
Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneityMOLECULAR PSYCHIATRYIF10.12014-09-09243OAAI
Reduced Phenotypic Severity Following Adeno-Associated Virus-Mediated Fmr1 Gene Delivery in Fragile X MiceNEUROPSYCHOPHARMACOLOGYIF7.12014-07-0776OAAI
Delayed myelination in a mouse model of fragile X syndromeHUMAN MOLECULAR GENETICSIF3.22013-06-0494PREAI
Pathways to Drug Development for Autism Spectrum DisordersCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52011-12-2851PREAI
Subchronic Administration and Combination Metabotropic Glutamate and GABAB Receptor Drug Therapy in Fragile X SyndromeJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82011-09-0154OAAI
The neurochemical basis for the treatment of autism spectrum disorders and Fragile X SyndromeBIOCHEMICAL PHARMACOLOGYIF5.62011-05-0131PREAI
Increased GABAB Receptor-Mediated Signaling Reduces the Susceptibility of Fragile X Knockout Mice to Audiogenic SeizuresMOLECULAR PHARMACOLOGYIF32009-07-01127PREAI
Isostructural fluorescent and radioactive probes for monitoring neural stem and progenitor cell transplantsNUCLEAR MEDICINE AND BIOLOGYIF32008-02-0148PREAI
Developmental expression of FMRP in the astrocyte lineage: Implications for fragile X syndromeGLIAIF5.12007-09-06121PREAI